{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T05:11:53Z","timestamp":1759813913597},"reference-count":121,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1016\/j.clindermatol.2006.07.008","type":"journal-article","created":{"date-parts":[[2006,9,11]],"date-time":"2006-09-11T11:12:21Z","timestamp":1157973141000},"page":"430-437","source":"Crossref","is-referenced-by-count":27,"title":["Rheumatoid arthritis in dermatology"],"prefix":"10.1016","volume":"24","author":[{"given":"Tissa","family":"Hata","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arthur","family":"Kavanaugh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2006.07.008_bib1","series-title":"Clinical immunology","author":"Kavanaugh","year":"2001"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib2","doi-asserted-by":"crossref","first-page":"3729","DOI":"10.1002\/art.20590","article-title":"No decrease over time in the incidence of vasculitis or other extraarticular manifestations in rheumatoid arthritis: results from a community-based study","volume":"50","author":"Turesson","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib3","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s002960050048","article-title":"Clinical diagnosis found in patients with Raynaud's phenomenon: a multicentre study","volume":"18","author":"Grassi","year":"1998","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib4","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1136\/ard.40.6.567","article-title":"The prevalence of Raynaud's syndrome in rheumatoid arthritis","volume":"40","author":"Carroll","year":"1981","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib5","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1093\/rheumatology\/35.8.752","article-title":"Raynaud's phenomenon in rheumatoid arthritis","volume":"35","author":"Saraux","year":"1996","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib6","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0889-857X(05)70300-8","article-title":"Raynaud's phenomenon","volume":"22","author":"Wigley","year":"1996","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib7","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1136\/ard.55.2.122","article-title":"Von Willebrand factor, thrombomodulin, thromboxane, beta-thromboglobulin and markers of fibrinolysis in primary Raynaud's phenomenon and systemic sclerosis","volume":"55","author":"Herrick","year":"1996","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib8","first-page":"1325","article-title":"Mechanisms of endothelial cell damage in systemic sclerosis and Raynaud's phenomenon","volume":"20","author":"Blann","year":"1993","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib9","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1002\/1529-0131(200008)43:8<1886::AID-ANR27>3.0.CO;2-S","article-title":"Increased alpha2-adrenergic constriction of isolated arterioles in diffuse scleroderma","volume":"43","author":"Flavahan","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib10","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/rheumatology\/keh390","article-title":"Calcium channel blockers for primary Raynaud's phenomenon: a meta-analysis","volume":"44","author":"Thompson","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib11","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1080\/03009740310004621","article-title":"Epidemiology of extra-articular manifestations in rheumatoid arthritis","volume":"33","author":"Turesson","year":"2004","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib12","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/0002-9343(73)90040-5","article-title":"The extra-articular features of rheumatoid arthritis. A systematic analysis of 127 cases","volume":"54","author":"Gordon","year":"1973","journal-title":"Am J Med"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib13","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1136\/ard.36.6.500","article-title":"Felty's syndrome. Clinical and serological analysis of 34 cases","volume":"36","author":"Sienknecht","year":"1977","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib14","series-title":"Rheumatoid arthritis: an illustrated guide to pathology, diagnosis, and management","author":"Schumacher","year":"1988"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib15","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0002-9343(84)90787-3","article-title":"Rheumatoid nodules. Review of the spectrum of associated conditions and proposal of a new classification, with a report of four seronegative cases","volume":"76","author":"Kaye","year":"1984","journal-title":"Am J Med"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib16","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/00005792-200107000-00006","article-title":"The HLA-DRB1*0401 allele and the development of methotrexate-induced accelerated rheumatoid nodulosis: a follow-up study of 79 Caucasian patients with rheumatoid arthritis","volume":"80","author":"Ahmed","year":"2001","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib17","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/art.1780330601","article-title":"The rheumatoid nodule","volume":"33","author":"Ziff","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib18","series-title":"Rheumatoid arthritis: etiology, diagnosis, management","author":"Berhard","year":"1985"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib19","series-title":"Andrew's diseases of the skin: clinical dermatology","author":"James","year":"2006"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib20","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/art.10776","article-title":"Cytokine profile of the rheumatoid nodule suggests that it is a Th1 granuloma","volume":"48","author":"Hessian","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib21","first-page":"1839","article-title":"Complement mediated vascular endothelial injury in rheumatoid nodules: a histopathological and immunohistochemical study","volume":"27","author":"Kato","year":"2000","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib22","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/rheumatology\/31.11.775","article-title":"Injection therapy of superficial rheumatoid nodules","volume":"31","author":"Ching","year":"1992","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib23","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/BF02031622","article-title":"Rapidly progressive glomerulonephritis with glomerular crescent formation in rheumatoid arthritis","volume":"4","author":"Breedveld","year":"1985","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib24","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1002\/art.1780310915","article-title":"Accelerated nodulosis and vasculitis during methotrexate therapy for rheumatoid arthritis","volume":"31","author":"Segal","year":"1988","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib25","first-page":"253","article-title":"The frequency of cutaneous vasculitis is not increased in patients with rheumatoid arthritis treated with methotrexate","volume":"23","author":"Kaye","year":"1996","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib26","first-page":"242","article-title":"Extraarticular manifestations of rheumatoid arthritis and HLA antigens in northern Italy","volume":"19","author":"Salvarani","year":"1992","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib27","first-page":"33","article-title":"Cause of death in 81 autopsied patients with rheumatoid arthritis","volume":"21","author":"Suzuki","year":"1994","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib28","first-page":"62","article-title":"Occurrence of extraarticular disease manifestations is associated with excess mortality in a community based cohort of patients with rheumatoid arthritis","volume":"29","author":"Turesson","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib29","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1136\/ard.55.3.190","article-title":"Factors associated with the development of vasculitis in rheumatoid arthritis: results of a case-control study","volume":"55","author":"Voskuyl","year":"1996","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib30","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/00005792-198611000-00002","article-title":"Rheumatoid vasculitis: survival and associated risk factors","volume":"65","author":"Vollertsen","year":"1986","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib31","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0889-857X(21)01070-X","article-title":"Vasculitis associated with rheumatoid arthritis","volume":"16","author":"Vollertsen","year":"1990","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib32","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/0002-9343(84)90654-5","article-title":"Intravenous cyclophosphamide plus methylprednisolone in treatment of systemic rheumatoid vasculitis","volume":"76","author":"Scott","year":"1984","journal-title":"Am J Med"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib33","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1136\/ard.46.10.727","article-title":"Clinical and serological features of severe vasculitis in rheumatoid arthritis: prognostic implications","volume":"46","author":"Geirsson","year":"1987","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib34","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jaad.2004.07.023","article-title":"Rheumatoid arthritis: a review of the cutaneous manifestations","volume":"53","author":"Sayah","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib35","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1365-2133.1965.tb14632.x","article-title":"Arteritis of rheumatoid arthritis","volume":"77","author":"Golding","year":"1965","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib36","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/0021-9681(63)90139-5","article-title":"The natural history of vascular lesions in rheumatoid arthritis","volume":"16","author":"Bywaters","year":"1963","journal-title":"J Chronic Dis"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib37","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1136\/ard.54.11.927","article-title":"Isolated nail fold vasculitis in rheumatoid arthritis","volume":"54","author":"Watts","year":"1995","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib38","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1136\/ard.62.5.407","article-title":"Diagnostic strategy for the assessment of rheumatoid vasculitis","volume":"62","author":"Voskuyl","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib39","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/00005792-198705000-00001","article-title":"The neurologic presentation of vasculitic and rheumatologic syndromes. A review","volume":"66","author":"Sigal","year":"1987","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib40","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1159\/000310151","article-title":"Retinal vasculitis as a complication of rheumatoid arthritis","volume":"201","author":"Matsuo","year":"1990","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib41","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/00005792-198107000-00004","article-title":"Systemic rheumatoid vasculitis: a clinical and laboratory study of 50 cases","volume":"60","author":"Scott","year":"1981","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib42","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1572-0241.1998.119_c.x","article-title":"Gastrointestinal infarction as a manifestation of rheumatoid vasculitis","volume":"93","author":"Babian","year":"1998","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib43","first-page":"2624","article-title":"Hepatic hemorrhage in malignant rheumatoid arthritis","volume":"91","author":"Mizuno","year":"1996","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib44","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1001\/archinte.151.11.2249","article-title":"Prednisone plus azathioprine treatment in patients with rheumatoid arthritis complicated by vasculitis","volume":"151","author":"Heurkens","year":"1991","journal-title":"Arch Intern Med"},{"issue":"2 Pt 2","key":"10.1016\/j.clindermatol.2006.07.008_bib45","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0190-9622(87)70212-6","article-title":"Low-dose methotrexate therapy for cutaneous vasculitis of rheumatoid arthritis","volume":"17","author":"Upchurch","year":"1987","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib46","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1136\/ard.62.6.587","article-title":"Successful treatment of severe rheumatoid vasculitis by infliximab","volume":"62","author":"Unger","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib47","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1111\/j.1365-2133.2005.06520.x","article-title":"Successful treatment of refractory rheumatoid arthritis\u2013associated leg ulcerations with adalimumab","volume":"152","author":"Hirche","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib48","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1468-3083.2005.01118.x","article-title":"Successful treatment of a leg ulcer occurring in a rheumatoid arthritis patient under leflunomide therapy","volume":"19","author":"Knab","year":"2005","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib49","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1177\/095952879708000106","article-title":"On a form of chronic joint disease in children","volume":"80","author":"Still","year":"1897","journal-title":"Med Chir Trans"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib50","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/art.1780250607","article-title":"Adult-onset Still's disease. Twenty-year follow-up and further studies of patients with active disease","volume":"25","author":"Elkon","year":"1982","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib51","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1136\/ard.54.7.587","article-title":"Epidemiology of adult Still's disease: estimate of the incidence by a retrospective study in west France","volume":"54","author":"Magadur-Joly","year":"1995","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib52","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.berh.2004.05.004","article-title":"Adult-onset Still's disease","volume":"18","author":"Kadar","year":"2004","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib53","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/00005792-198403000-00002","article-title":"Adult Still's disease. Evolution of a clinical syndrome and diagnosis, treatment, and follow-up of 17 patients","volume":"63","author":"Larson","year":"1984","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib54","first-page":"2067","article-title":"Intravenous immunoglobulin in the treatment of refractory adult Still's disease","volume":"26","author":"Mahmud","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib55","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1002\/art.21061","article-title":"Rapid responses to anakinra in patients with refractory adult-onset Still's disease","volume":"52","author":"Fitzgerald","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib56","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1046\/j.1365-2133.1997.20022083.x","article-title":"Pyoderma gangrenosum: a report of 44 cases with follow-up","volume":"137","author":"von den Driesch","year":"1997","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib57","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/S0190-9622(00)90292-5","article-title":"Parastomal pyoderma gangrenosum: clinical features and management","volume":"42","author":"Lyon","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib58","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0020-7292(91)90823-N","article-title":"Vulvar pyoderma gangrenosum","volume":"35","author":"McCalmont","year":"1991","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib59","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0190-9622(96)90428-4","article-title":"Pyoderma gangrenosum: classification and management","volume":"34","author":"Powell","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib60","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0733-8635(02)00006-2","article-title":"Neutrophilic dermatoses","volume":"20","author":"Callen","year":"2002","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib61","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1046\/j.1523-1747.1998.00311.x","article-title":"Aberrant neutrophil trafficking and metabolic oscillations in severe pyoderma gangrenosum","volume":"111","author":"Adachi","year":"1998","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib62","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/j.1365-4362.1992.tb02723.x","article-title":"Pyoderma gangrenosum: associations revisited","volume":"31","author":"Ko","year":"1992","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib63","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1001\/archderm.106.4.599c","article-title":"Triamcinolone and pyoderma gangrenosum","volume":"106","author":"Gardner","year":"1972","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib64","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1046\/j.1365-2133.2002.495514.x","article-title":"Topical platelet-derived growth factor accelerates healing of myelodysplastic syndrome\u2013associated pyoderma gangrenosum","volume":"147","author":"Braun-Falco","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib65","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1365-2133.1980.tb05698.x","article-title":"The treatment of pyoderma gangrenosum with sodium cromoglycate","volume":"102","author":"de Cock","year":"1980","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib66","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1365-2230.1992.tb00254.x","article-title":"Pyoderma gangrenosum\u2014response to topical nitrogen mustard","volume":"17","author":"Tsele","year":"1992","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib67","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2165\/00128071-200203030-00002","article-title":"Clinical management of pyoderma gangrenosum","volume":"3","author":"Wollina","year":"2002","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib68","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1046\/j.1468-3083.2000.00019.x","article-title":"Treatment of recalcitrant ulcers in pyoderma gangrenosum with mycophenolate mofetil and autologous keratinocyte transplantation on a hyaluronic acid matrix","volume":"14","author":"Wollina","year":"2000","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib69","doi-asserted-by":"crossref","first-page":"41046","DOI":"10.1074\/jbc.M109443200","article-title":"Angiogenic oligosaccharides of hyaluronan induce multiple signaling pathways affecting vascular endothelial cell mitogenic and wound healing responses","volume":"277","author":"Slevin","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib70","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1159\/000068887","article-title":"Resolution of pyoderma gangrenosum after therapy with lyophilized bovine collagen matrix","volume":"206","author":"Farris","year":"2003","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib71","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1046\/j.1365-2133.1999.02746.x","article-title":"Combination oral and topical tacrolimus in therapy-resistant pyoderma gangrenosum","volume":"140","author":"Jolles","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib72","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1046\/j.1365-4362.2002.01680_3.x","article-title":"Pyoderma gangrenosum of the scalp treated with cyclosporine A","volume":"41","author":"Patrone","year":"2002","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib73","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1046\/j.1365-2133.2000.03606.x","article-title":"Pyoderma gangrenosum in a patient with autoimmune haemolytic anaemia and complement deficiency","volume":"143","author":"Coors","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib74","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1046\/j.1365-2230.1999.00424.x","article-title":"Plasmapheresis and cyclophosphamide as successful treatments for pyoderma gangrenosum","volume":"24","author":"Kaminska","year":"1999","journal-title":"Clin Exp Dermatol"},{"issue":"5 Pt 1","key":"10.1016\/j.clindermatol.2006.07.008_bib75","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/S0190-9622(96)90727-6","article-title":"Chlorambucil is an effective corticosteroid-sparing agent for recalcitrant pyoderma gangrenosum","volume":"35","author":"Burruss","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib76","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1046\/j.1365-2133.1998.02440.x","article-title":"Pyoderma gangrenosum with rheumatoid arthritis and pulmonary aseptic abscess responding to treatment with dapsone","volume":"139","author":"Fukuhara","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib77","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0190-9622(81)70018-5","article-title":"Pyoderma gangrenosum treated with clofazimine. Report of three cases","volume":"4","author":"Kark","year":"1981","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib78","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/S0190-9622(98)70513-4","article-title":"Recalcitrant pyoderma gangrenosum: treatment with thalidomide","volume":"38","author":"Hecker","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib79","doi-asserted-by":"crossref","first-page":"538","DOI":"10.2340\/00015555-70538539","article-title":"Response of atypical bullous pyoderma gangrenosum to oral minocycline hydrochloride and topical steroids","volume":"70","author":"Reynolds","year":"1990","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib80","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1046\/j.1365-2133.1999.02745.x","article-title":"Recalcitrant pyoderma gangrenosum treated with systemic tacrolimus","volume":"140","author":"Lyon","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib81","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1001\/archderm.134.12.1509","article-title":"The effectiveness of mycophenolate mofetil in refractory pyoderma gangrenosum","volume":"134","author":"Nousari","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib82","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/j.1365-2133.2005.06812.x","article-title":"Severe recalcitrant pyoderma gangrenosum treated with infliximab","volume":"153","author":"Kaur","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib83","series-title":"Histopathologic diagnosis of inflammatory skin diseases: a method by pattern analysis","author":"Ackerman","year":"1978"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib84","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1046\/j.1365-2133.2000.03565.x","article-title":"Rheumatoid neutrophilic dermatitis associated with pyoderma gangrenosum","volume":"142","author":"MacAya","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib85","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1600-0560.1992.tb01558.x","article-title":"Rheumatoid neutrophilic dermatitis","volume":"19","author":"Lowe","year":"1992","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib86","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1001\/archderm.133.6.757","article-title":"Rheumatoid neutrophilic dermatitis","volume":"133","author":"Mashek","year":"1997","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib87","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1001\/archderm.125.8.1105","article-title":"Rheumatoid neutrophilic dermatitis","volume":"125","author":"Scherbenske","year":"1989","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib88","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/j.1365-4362.1994.tb01000.x","article-title":"Rheumatoid neutrophilic dermatitis","volume":"33","author":"Yamamoto","year":"1994","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib89","first-page":"203","article-title":"Rheumatoid neutrophilic dermatitis","volume":"60","author":"Hirota","year":"1997","journal-title":"Cutis"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib90","doi-asserted-by":"crossref","unstructured":"Harkaway K, Elenitas R, Margolis DJ. Erythematous papules in a patient with rheumatoid arthritis. Rheumatoid neutrophilic dermatitis (RND). Arch Dermatol 1995;131:1196, 1199-200.","DOI":"10.1001\/archderm.1995.01690220105020"},{"issue":"5 Pt 2","key":"10.1016\/j.clindermatol.2006.07.008_bib91","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/0190-9622(90)70127-4","article-title":"Rheumatoid neutrophilic dermatitis","volume":"22","author":"Sanchez","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib92","first-page":"1881","article-title":"The evolving use of tumor necrosis factor inhibitors in rheumatoid arthritis","volume":"31","author":"Kavanaugh","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib93","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.jaci.2005.03.028","article-title":"Adverse reactions to biologic agents: focus on autoimmune disease therapies","volume":"116","author":"Lee","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib94","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.rdc.2004.02.003","article-title":"Safety overview of new disease-modifying antirheumatic drugs","volume":"30","author":"Cush","year":"2004","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib95","first-page":"893","article-title":"Clinical, histological, and immunophenotypic characteristics of injection site reactions associated with etanercept: a recombinant tumor necrosis factor alpha receptor: Fc fusion protein","volume":"137","author":"Zeltser","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib96","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1111\/j.1572-0241.2002.05784.x","article-title":"Infliximab retreatment in adults and children with Crohn's disease: risk factors for the development of delayed severe systemic reaction","volume":"97","author":"Kugathasan","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib97","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/S0140-6736(02)08512-4","article-title":"Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial","volume":"359","author":"Hanauer","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib98","first-page":"1912","article-title":"Infusion-related reactions to infliximab in patients with rheumatoid arthritis in a clinical practice setting: relationship to dose, antihistamine pretreatment, and infusion number","volume":"31","author":"Wasserman","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib99","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1111\/j.1572-0241.2003.07457.x","article-title":"The incidence and management of infusion reactions to infliximab: a large center experience","volume":"98","author":"Cheifetz","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib100","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1053\/j.gastro.2003.10.047","article-title":"The safety profile of infliximab in patients with Crohn's disease: the Mayo clinic experience in 500 patients","volume":"126","author":"Colombel","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib101","first-page":"1955","article-title":"Leukocytoclastic vasculitis associated with tumor necrosis factor-alpha blocking agents","volume":"31","author":"Mohan","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib102","first-page":"2041","article-title":"Leukocytoclastic vasculitis due to etanercept","volume":"27","author":"Galaria","year":"2000","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib103","first-page":"2287","article-title":"Anti-tumor necrosis factor-alpha therapy\u2013induced vasculitis: case series","volume":"30","author":"Jarrett","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib104","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1093\/rheumatology\/41.10.1126","article-title":"Efficacy of the anti\u2013TNF-alpha antibody infliximab against refractory systemic vasculitides: an open pilot study on 10 patients","volume":"41","author":"Bartolucci","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib105","first-page":"1885","article-title":"Tumor necrosis factor-alpha blockade and the risk of vasculitis","volume":"31","author":"Guillevin","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib106","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1002\/art.10524","article-title":"Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study","volume":"46","author":"Doran","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib107","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0889-857X(02)00101-1","article-title":"Infection complications associated with the use of biologic agents","volume":"29","author":"Bresnihan","year":"2003","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib108","doi-asserted-by":"crossref","first-page":"4320","DOI":"10.4049\/jimmunol.158.9.4320","article-title":"Programmed cell death of Mycobacterium avium serovar 4\u2013infected human macrophages prevents the mycobacteria from spreading and induces mycobacterial growth inhibition by freshly added, uninfected macrophages","volume":"158","author":"Fratazzi","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib109","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJMoa011110","article-title":"Tuberculosis associated with infliximab, a tumor necrosis factor alpha\u2013neutralizing agent","volume":"345","author":"Keane","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib110","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1136\/ard.2004.024737","article-title":"Anti\u2013tumour necrosis factor alpha therapy in rheumatoid arthritis: an update on safety","volume":"63","author":"Hyrich","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib111","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1002\/art.11301","article-title":"Infections and anti\u2013tumor necrosis factor alpha therapy","volume":"48","author":"Ellerin","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib112","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1002\/art.11151","article-title":"Salmonella septicemia in rheumatoid arthritis patients receiving anti\u2013tumor necrosis factor therapy: association with decreased interferon-gamma production and Toll-like receptor 4 expression","volume":"48","author":"Netea","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib113","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1136\/pmj.78.915.47","article-title":"Necrotising fasciitis in a patient receiving infliximab for rheumatoid arthritis","volume":"78","author":"Chan","year":"2002","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib114","doi-asserted-by":"crossref","first-page":"653","DOI":"10.4065\/76.6.653","article-title":"Fatal sepsis in a patient with rheumatoid arthritis treated with etanercept","volume":"76","author":"Baghai","year":"2001","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib115","doi-asserted-by":"crossref","first-page":"R666","DOI":"10.1186\/ar1724","article-title":"Dermatological conditions during TNF-alpha\u2013blocking therapy in patients with rheumatoid arthritis: a prospective study","volume":"7","author":"Flendrie","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib116","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1002\/art.21233","article-title":"Psoriasis induced by anti-tumor necrosis factor therapy: a paradoxical adverse reaction","volume":"52","author":"Sfikakis","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib117","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1345\/aph.1C477","article-title":"Psoriasiform eruption induced by infliximab","volume":"38","author":"Verea","year":"2004","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib118","first-page":"439","article-title":"Pustular psoriasis induced by infliximab","volume":"3","author":"Thurber","year":"2004","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib119","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1002\/art.20155","article-title":"Skin reaction to adalimumab","volume":"50","author":"Beuthien","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"Suppl 2","key":"10.1016\/j.clindermatol.2006.07.008_bib120","doi-asserted-by":"crossref","first-page":"ii87","DOI":"10.1136\/ard.2004.032276","article-title":"Psoriasis treatment: current and emerging directed therapies","volume":"64","author":"Winterfield","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clindermatol.2006.07.008_bib121","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/00002281-200307000-00003","article-title":"Tumor necrosis factor biology in experimental and clinical arthritis","volume":"15","author":"Sfikakis","year":"2003","journal-title":"Curr Opin Rheumatol"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X06001003?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X06001003?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T11:22:21Z","timestamp":1707218541000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X06001003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":121,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["S0738081X06001003"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2006.07.008","relation":{},"ISSN":["0738-081X"],"issn-type":[{"value":"0738-081X","type":"print"}],"subject":[],"published":{"date-parts":[[2006,9]]}}}